Form 8-K - Current report:
SEC Accession No. 0001193125-24-174317
Filing Date
2024-07-02
Accepted
2024-07-02 16:05:53
Documents
13
Period of Report
2024-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d781953d8k.htm   iXBRL 8-K 25877
  Complete submission text file 0001193125-24-174317.txt   148054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20240627.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20240627_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20240627_pre.xml EX-101.PRE 11261
15 EXTRACTED XBRL INSTANCE DOCUMENT d781953d8k_htm.xml XML 3627
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 241095135
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)